Global Heparin Market 2020-2024 | Evolving Opportunities with Aspen Pharmacare Holdings Ltd. and Baxter International Inc. | Technavio

LONDON--(BUSINESS WIRE)-- Technavio has been monitoring the global heparin market since 2015 and the market is poised to grow by USD 941.2 million during 2020-2024, progressing at a CAGR of almost 3% during the forecast period. Request free sample pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200122005479/en/

Technavio has announced its latest market research report titled global heparin market 2020-2024 (Graphic: Business Wire)

Read the 166-page report with TOC on “Heparin Market Analysis Report by Geography (Asia, Europe, North America, and ROW), Product (low-molecular-weight heparin and others), Route of Administration (subcutaneous injection and intravenous/infusion), and the Segment Forecasts, 2020-2024”.

https://www.technavio.com/report/heparin-market-industry-analysis

The market is driven by the increasing prevalence of chronic conditions. In addition, the development of drugs to remove heparin after surgery is anticipated to boost the growth of the heparin market.

Globally, the prevalence of chronic conditions, such as cardiovascular diseases, kidney disease, and inflammatory conditions have been on the rise. This is due to a rise in risk factors such as lack of physical activity, poor nutrition, alcohol consumption, and smoking. In addition, the growing prevalence of obesity has increased the incidences of cardiovascular diseases, such as deep vein thrombosis and pulmonary embolism. Anticoagulants, such as heparin are widely used to treat and prevent clots in patients with cardiovascular diseases. This is because heparin decreases blood’s ability to clot and also prevents existing clots from getting larger. Therefore, with the growing prevalence of chronic diseases, the demand for anticoagulants such as heparin will increase during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Heparin Market Companies:

Aspen Pharmacare Holdings Ltd.

Aspen Pharmacare Holdings Ltd. operates its business through segments such as Commercial Pharmaceuticals and Manufacturing. Some of the key offerings of the company include FRAXIPARINE, Fraxodi, and Arixtra.

Baxter International Inc.

Baxter International Inc. operates its business through segments such as Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, and Advanced Surgery, Acute Therapies, and Others. Heparin sodium is the key offering of the company.

Eisai Co. Ltd.

Eisai Co. Ltd. operates its business through segments such as Pharmaceutical and Others. FRAGMIN is the key offering of the company.

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA operates the business through segments such as Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. Heparin sodium is the key offering of the company.

Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc operates its business through segments such as Branded, Injectables, Generics, and Others. Heparin sodium injection and Heparin sodium injection (prefilled syringe) are the key offerings of the company.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Heparin Product Outlook (Revenue, USD Million, 2020 - 2024)

• Low-molecular-weight heparin
• Others

Heparin Route of Administration Outlook (Revenue, USD Million, 2020 - 2024)

• Subcutaneous injection
• Intravenous/infusion

Heparin Regional Outlook (Revenue, USD Million, 2020 - 2024)

• Asia
• Europe
• North America
• ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Healthcare are:

Global Cardiovascular Therapeutics Market – Global cardiovascular therapeutics market by geography (Asia, Europe, North America, and ROW) and product (antihypertensive drugs, hypolipidemic drugs, antithrombotic drugs, and other drugs).

Global Pulmonary Embolism Therapeutics Market – Global pulmonary embolism therapeutics market by route of administration (oral and parenteral) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20200122005479/en/